Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination.

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis (2015) 2.48

Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study. PLoS One (2015) 1.41

Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review. Adv Ther (2015) 0.90

Understanding Toxoplasmosis in the United States Through "Large Data" Analyses. Clin Infect Dis (2016) 0.78

The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model. Hum Vaccin Immunother (2016) 0.78

Correlates of human papillomavirus vaccine coverage: a state-level analysis. Sex Transm Dis (2015) 0.78

Development and initial feedback about a human papillomavirus (HPV) vaccine comic book for adolescents. J Cancer Educ (2014) 0.76

Trends in Genital Warts in the Era of Human Papillomavirus Vaccination. Sex Transm Dis (2015) 0.75

Impact of HPV vaccination on anogenital warts and respiratory papillomatosis. Hum Vaccin Immunother (2016) 0.75

Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009-2012. Prev Med (2017) 0.75

Recurrent and Sustained Viral Infections in Primary Immunodeficiencies. Front Immunol (2017) 0.75

Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data. BMC Infect Dis (2017) 0.75

Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep (2010) 14.85

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med (2007) 12.17

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet (2001) 7.31

Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81

Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep (2011) 4.68

FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep (2010) 4.34

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA (2001) 4.26

The epidemiology of human papillomavirus infections. J Clin Virol (2005) 3.63

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ (2010) 3.41

FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep (2010) 3.35

National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008. MMWR Morb Mortal Wkly Rep (2009) 3.17

National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011. MMWR Morb Mortal Wkly Rep (2012) 3.04

Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis (2009) 2.92

National, state, and local area vaccination coverage among adolescents aged 13-17 years --- United States, 2009. MMWR Morb Mortal Wkly Rep (2010) 2.74

The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis (2003) 2.72

Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health (1999) 2.54

Gardasil: from bench, to bedside, to blunder. Lancet (2010) 2.51

Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis (2005) 2.51

Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med (2008) 2.49

American adolescents: sexual mixing patterns, bridge partners, and concurrency. Sex Transm Dis (2002) 2.43

Vaccination coverage among adolescents aged 13-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep (2008) 2.31

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect (2009) 2.30

External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis (2002) 2.05

The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect (2011) 1.61

Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev Med (2010) 1.45

Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Curr Med Res Opin (2009) 1.30

Post-licensure monitoring of HPV vaccine in the United States. Vaccine (2010) 1.24

Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis (2004) 1.20

Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis (2012) 1.18

Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010. Am J Public Health (2012) 1.13

Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics (2012) 1.10

Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy. Sex Health (2010) 0.96

Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries. Vaccine (2010) 0.92

What can surveillance of genital warts tell us? Sex Health (2010) 0.91

Partner age difference and prevalence of chlamydial infection among young adult women. Sex Transm Dis (2008) 0.91

Population effectiveness, not efficacy, should decide who gets vaccinated against human papillomavirus via publicly funded programs. J Infect Dis (2011) 0.88

Monitoring the impact of vaccines postlicensure: new challenges, new opportunities. Expert Rev Vaccines (2008) 0.81

Increasing uptake of Gardasil among American adolescents: comparisons with the history of Hepatitis B vaccination. Hum Vaccin (2011) 0.77

Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis (2013) 5.40

Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals. J Acquir Immune Defic Syndr (2006) 4.71

Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates. Open AIDS J (2012) 4.20

ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol (2010) 4.16

Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med (2007) 3.20

Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med (2008) 2.98

Sexual and reproductive health of persons aged 10-24 years - United States, 2002-2007. MMWR Surveill Summ (2009) 2.89

Primary and secondary syphilis--United States, 2005-2013. MMWR Morb Mortal Wkly Rep (2014) 2.73

Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res (2002) 2.45

Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol (2008) 1.94

A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation. J Virol (2003) 1.63

Retinoic acid deficiency alters second heart field formation. Proc Natl Acad Sci U S A (2008) 1.51

Vitamin D deficiency in children with fractures. Pediatr Emerg Care (2014) 1.46

Independent requirements for Hedgehog signaling by both the anterior heart field and neural crest cells for outflow tract development. Development (2007) 1.43

Signaling via the Tgf-beta type I receptor Alk5 in heart development. Dev Biol (2008) 1.42

Chlamydia positivity trends among women attending family planning clinics: United States, 2004-2008. Sex Transm Dis (2011) 1.41

Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008. Sex Transm Dis (2012) 1.41

Multidetector CT coronary angiography for patient triage to invasive coronary angiography: Performance and cost in ambulatory patients with equivocal or suspected inaccurate noninvasive stress tests. Catheter Cardiovasc Interv (2009) 1.38

Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abus (2012) 1.36

Gonococcal, chlamydia, and syphilis infection positivity among MSM attending a large primary care clinic, Boston, 2003 to 2004. Sex Transm Dis (2009) 1.32

"I wish we could normalize driving health:" a qualitative study of clinician discussions with older drivers. J Gen Intern Med (2013) 1.29

Prevalence and correlates of purchasing contraband cigarettes on First Nations reserves in Ontario, Canada. Addiction (2009) 1.28

Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012. MMWR Morb Mortal Wkly Rep (2014) 1.27

HIV incidence in the United States, 1978-1999. J Acquir Immune Defic Syndr (2002) 1.26

Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012. Clin Infect Dis (2014) 1.25

Validation of the palliative performance scale in the acute tertiary care hospital setting. J Palliat Med (2007) 1.25

Comparative analysis of two commercial phenotypic assays for drug susceptibility testing of human immunodeficiency virus type 1. J Clin Microbiol (2002) 1.24

Juveniles' competence to stand trial: a comparison of adolescents' and adults' capacities as trial defendants. Law Hum Behav (2003) 1.15

Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine. J Virol (2004) 1.13

Assessing neonatal herpes reporting in the United States, 2000-2005. Sex Transm Dis (2008) 1.13

Incidence of neonatal herpes simplex virus infections in the United States, 2006. Pediatrics (2010) 1.10

A participatory action research pilot study of urban health disparities using rapid assessment response and evaluation. Am J Public Health (2007) 1.07

Long-term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population. Sex Transm Dis (2012) 1.06

Characteristics of persons with recently acquired HIV infection: application of the serologic testing algorithm for recent HIV seroconversion in 10 US cities. J Acquir Immune Defic Syndr (2007) 1.06

A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model. J Subst Abuse Treat (2006) 1.05

A multicenter randomized evaluation of methadone medical maintenance. Drug Alcohol Depend (2002) 1.03

Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. [corrected] Proc Natl Acad Sci U S A (2011) 1.02

A Trich-y question: should Trichomonas vaginalis infection be reportable? Sex Transm Dis (2013) 1.02

Estimates of Chlamydia trachomatis infections among men: United States. Sex Transm Dis (2008) 1.01

Do components of current 'hardcore smoker' definitions predict quitting behaviour? Addiction (2012) 1.01

Pharyngeal gonorrhea: an important reservoir of infection? Clin Infect Dis (2009) 0.98

Chlamydia prevalence among women and men entering the National Job Training Program: United States, 2003-2007. Sex Transm Dis (2010) 0.97

Increase in Incidence of Congenital Syphilis - United States, 2012-2014. MMWR Morb Mortal Wkly Rep (2015) 0.96

Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States. Emerg Infect Dis (2012) 0.95

Clinical manifestations and treatment outcome of optic neuropathy in thyroid-related orbitopathy. Ophthalmic Surg Lasers Imaging (2006) 0.92

Public support for smoke-free areas in Israel: a case for action. Health Policy (2012) 0.92

Long-term efficacy and safety of tipranavir boosted with ritonavir in HIV-1-infected patients failing multiple protease inhibitor regimens: 80-week data from a phase 2 study. J Acquir Immune Defic Syndr (2007) 0.92

A pilot study to develop a brief question-based screening tool to identify higher-risk older drivers. J Am Geriatr Soc (2012) 0.92

Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009. Cancer Causes Control (2014) 0.92

Feasibility of referring drug users from a needle exchange program into an addiction treatment program: experience with a mobile treatment van and LAAM maintenance. J Subst Abuse Treat (2003) 0.92

Pharmacist-led, interdisciplinary model for delivery of supportive care in the ambulatory cancer clinic setting. J Oncol Pract (2010) 0.91

Changes in 24-h substrate oxidation in older and younger men in response to exercise. J Appl Physiol (1985) (2007) 0.91

Treatment entry among individuals on a waiting list for methadone maintenance. Am J Drug Alcohol Abuse (2009) 0.90

Prevalence of genital warts among sexually transmitted disease clinic patients-sexually transmitted disease surveillance network, United States, January 2010 to December 2011. Sex Transm Dis (2014) 0.89

Heroin detoxification with buprenorphine on an inpatient psychiatric unit. J Subst Abuse Treat (2002) 0.89

Driving rehabilitation programs for older drivers in the United States. Occup Ther Health Care (2014) 0.89

Exploring the adequacy of smoking cessation support for pregnant and postpartum women. BMC Public Health (2013) 0.88

HIV testing among patients infected with Neisseria gonorrhoeae: STD Surveillance Network, United States, 2009-2010. AIDS Behav (2013) 0.88

Older adult opinions of "advance driving directives". J Prim Care Community Health (2012) 0.87

Transitions in smoking status over time in a population-based panel study of smokers. Nicotine Tob Res (2012) 0.87

Modeling the impact of quadrivalent HPV vaccination on the incidence of Pap test abnormalities in the United States. Vaccine (2013) 0.87

Syphilis in the United States: on the rise? Expert Rev Anti Infect Ther (2014) 0.86

Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertension. J Perinat Med (2004) 0.85

Predicting demographic group structures based on DNA sequence data. Mol Biol Evol (2003) 0.84

Do health policy advisors know what the public wants? An empirical comparison of how health policy advisors assess public preferences regarding smoke-free air, and what the public actually prefers. Isr J Health Policy Res (2013) 0.83

Efficacy, safety and pharmacokinetics of once-daily saquinavir soft-gelatin capsule/ritonavir in antiretroviral-naive, HIV-infected patients. MedGenMed (2006) 0.83

Changes in fluoroquinolone use for gonorrhea following publication of revised treatment guidelines. Am J Public Health (2011) 0.83

State-Specific Rates of Primary and Secondary Syphilis Among Men Who Have Sex with Men - United States, 2015. MMWR Morb Mortal Wkly Rep (2017) 0.83

Prevalence of high-risk HPV types and abnormal cervical cytology in American Indian/Alaska Native women, 2003-2005. Public Health Rep (2011) 0.82

Older adult opinions about driving cessation: a role for advanced driving directives. J Prim Care Community Health (2012) 0.82

U.S. abortion in context: selected characteristics and motivations of women seeking abortions. J Soc Issues (1992) 0.82

Smoking low-cost cigarettes: disparities evident. Can J Public Health (2011) 0.82

Early syphilis in the United States identified in corrections facilities, 1999-2002. Sex Transm Dis (2004) 0.81

Unexpected suicidality in an older individual in an emergency department. J Am Geriatr Soc (2013) 0.81

Feasibility of an internet-based intervention for improving diabetes outcomes among low-income patients with a high risk for poor diabetes outcomes followed in a community clinic. Diabetes Educ (2013) 0.80

The proximity of predominantly African American and Hispanic rural communities to physicians and hospital services. J Rural Health (2002) 0.80

A tale of two gonorrhea epidemics: results from the STD surveillance network. Public Health Rep (2012) 0.79

A molecular star in the wars against cancer. N Engl J Med (2002) 0.79

Dropout from interim methadone and subsequent comprehensive methadone maintenance. Am J Drug Alcohol Abuse (2009) 0.79

Patterns of cigarillo use among Canadian young adults in two urban settings. Can J Public Health (2014) 0.79

A common public health-oriented policy framework for cannabis, alcohol and tobacco in Canada? Can J Public Health (2016) 0.78

Detection of pelvic inflammatory disease: development of an automated case-finding algorithm using administrative data. Infect Dis Obstet Gynecol (2011) 0.78

Chlamydia trachomatis infections among women attending prenatal clinics: United States, 2004-2009. Sex Transm Dis (2012) 0.78

Recruitment of older drivers from primary care clinics for on-road fitness-to-drive testing: results of a pilot study. J Am Geriatr Soc (2014) 0.78

Gonorrhoea positivity among women aged 15-24 years in the USA, 2005-2007. Sex Transm Infect (2011) 0.78

Synergistic effect of cardiovascular risk factors on necrotic core in coronary arteries: a report from the global intravascular radiofrequency data analysis registry. JACC Cardiovasc Imaging (2009) 0.78

Merkel cell carcinoma: is this a true carcinoma? Exp Dermatol (2014) 0.78

Responding to the burden of STD, HIV, and viral hepatitis in correctional populations through program collaboration and integration. Sex Transm Dis (2009) 0.78

Rogers v. Whitaker and informed consent in Australia: a fair dinkum duty of disclosure. Med Law Rev (1993) 0.78

Gonorrhea treatment practices in the STD Surveillance Network, 2010-2012. Sex Transm Dis (2015) 0.77

Antimicrobial resistant gonorrhea in Atlanta: 1988-2006. Sex Transm Dis (2011) 0.77

Association between tobacco vendor non-compliance with youth access and point of sale restrictions. Tob Control (2009) 0.76

Amniotic fluid erythropoietin concentrations differentiate between acute and chronic causes of fetal death. Acta Obstet Gynecol Scand (2002) 0.76

Why a teenager over age 14 should be able to consent, rather than merely assent, to participation as a human subject of research. Am J Bioeth (2003) 0.75

Would young women attending sexually transmitted disease clinics benefit from human papillomavirus vaccination? An assessment of human papillomavirus DNA and seropositivity from human papillomavirus sentinel surveillance, 2003-2005. Sex Transm Dis (2014) 0.75

Reoperation choices: what would you do? J Pediatr Ophthalmol Strabismus (2004) 0.75

Interpretation of high-throughput liquid chromatography mass spectrometry data for quality control analysis and analytical method development. Comb Chem High Throughput Screen (2005) 0.75

Analysis of on-line clinical laboratory manuals and practical recommendations. Arch Pathol Lab Med (2004) 0.75

Implications of proprotein Convertase 5 (PC5) in the arterial restenotic process in a porcine model. Cardiovasc Pathol (2004) 0.75

Neighborhoods at risk: estimating risk of higher Neisseria gonorrhoeae incidence among women at the census tract level. Sex Transm Dis (2014) 0.75